A major investment bank has set a target price significantly above the consensus for Broadcom (NASDAQ: AVGO), with Exane BNP Paribas raising its price target to $675, implying a potential upside of 61%. Of the 44 analysts covering the stock, all give it a Buy rating, with no Sell recommendations. Over the past three months, while shares of Advanced Micro Devices have gained 14% and Marvell Technology has surged 26%, Broadcom's stock has stalled. However, its artificial intelligence-related revenue surged 143% year-over-year. CEO Hock Tan confirmed that the company's second-quarter AI orders reached $30 billion, with actual shipments totaling $10.8 billion, targeting $100 billion in AI business revenue by fiscal 2027.
Broadcom is currently trading at $417.82, with a consensus analyst price target of $527.88, implying a potential upside of about 26%. The company is the second-largest independent semiconductor firm by market capitalization, valued at $1.99 trillion. Its two core growth engines are custom AI accelerators and networking chips for hyperscale cloud providers, along with the VMware infrastructure software business. CEO Hock Tan has publicly stated a goal to exceed $100 billion in AI chip revenue by fiscal 2027, a target that could reshape the AI supply chain landscape.
Why Broadcom Has Languished While AI Peers Have Surged
Broadcom has fallen 1.57% over the past three months, a figure that does not fully capture the extent of the pullback. On June 3, 2026, when the company reported its second-quarter results, the stock was at $495. Despite beating expectations across the board, shares subsequently declined to the $410 range. The sell-off has been primarily driven by valuation concerns, not a deterioration in fundamentals. The company's forward price-to-earnings ratio is near 69 times. After an initial post-earnings spike, capital rotated toward lower-valuation AI chip stocks. Over the same period, Nvidia's shares were flat, AMD rose 13.89%, and Marvell soared 25.64%, making Broadcom a clear laggard in the sector. Market sentiment indicators confirm this trend: Broadcom's composite trading prediction and sentiment index is only 35.03, leaning bearish, with the 30-day sentiment indicator declining by 24.64 points. Despite continued fundamental strength, trading capital has remained cautious.
The Logic Behind Analyst Expectations for a Higher Share Price
The bull case is built on Broadcom's second-quarter results, which exceeded expectations across all metrics. The company reported revenue of $22.19 billion, up 47.9% year-over-year, and non-GAAP earnings per share of $2.44, marking the eighth consecutive quarter of earnings beats. AI chip revenue reached $10.8 billion, up a massive 143% year-over-year. Management has guided for third-quarter AI revenue of $16 billion, representing year-over-year growth of over 200%. Currently, 44 analysts rate the stock a Buy, four rate it a Hold, and none recommend selling. Following the June earnings report, several firms raised their price targets, with mainstream targets clustering in the $525-$585 range: Evercore ISI has a target of $582, KeyBanc $575, and Truist and Jefferies both set targets of $550.
Exane BNP Paribas has set the highest market target at $675, supported by three key factors. First, custom AI application-specific integrated circuits continue to solidify Broadcom's advantage, covering projects like Google's TPU, Meta's MTIA chip, and expanding partnerships with Apple. Second, demand for "Tomahawk 5/6" switching chips, PCIe switches, and optical interconnect products is rising. Third, the conversion of VMware's subscription business is driving margin expansion. During the earnings call, Hock Tan stated that "demand for XPU and networking chips is nearly infinite," confirming that second-quarter AI orders exceeded $30 billion, compared to $10.8 billion in recognized shipment revenue for the same period. Analysts are focusing on fiscal 2027. The company has guided for full-year fiscal 2026 AI chip revenue of $56 billion, up roughly 180% from fiscal 2025, with a fiscal 2027 AI revenue target exceeding $100 billion. If this target is met, the consensus price target of $527.88 would appear conservative.
The Only AI Chip Stock to Miss the Recent Rally
Nvidia is currently trading at $225.30, with an average analyst target of $302.83, implying a potential gain of about 34%, supported by 58 Buy ratings, two Holds, and one Sell. As Blackwell Ultra chips ramp up production, institutions continue to raise expectations. AMD is trading at $483.01, up 125.54% year-to-date, with a consensus target of $613.33, suggesting a potential gain of about 27%. Orders for MI450 chips from OpenAI and Meta have been priced into the market, with 41 Buy and 10 Hold ratings. Marvell Technology is trading at $222.18, up 161.83% year-to-date, with an average target of $256.91, offering a potential upside of about 16%, backed by 38 Buy and five Hold ratings. After significant gains, Marvell has the smallest upside buffer among the group. Among all stocks in the sector, Exane BNP Paribas's $675 target for Broadcom represents the highest potential upside. Based on institutional analysis, Broadcom currently has the largest gap between its current price and its fundamental value expectations among all AI chip companies.
Stock Price Performance Overview
Broadcom is up 21.17% year-to-date and 36.17% over the past year, outperforming the S&P 500, which has gained 14.07% year-to-date. However, over the last three months, Broadcom's stock has traded sideways while the broader market has continued to climb. At a current price of $417.82, the consensus target from 48 tracking firms is $527.88, implying a potential gain of about 26%. Exane BNP Paribas's market-high target of $675 suggests a potential upside of just over 61%. Fundamental support includes second-quarter free cash flow of $10.26 billion, third-quarter adjusted EBITDA margin guidance of approximately 68%, and $19.63 billion in cash on hand.
Key Conclusions
The bull case hinges on market acceptance of the $100 billion AI chip revenue target for fiscal 2027. Feasibility is supported by the earnings call, which mentioned collaborations including Google's TPU, Meta's MTIA, OpenAI's custom chip deployment, and Anthropic's compute procurement. Second-quarter order volume was 2.8 times the recognized shipment revenue. If the backlog of orders is converted into revenue, the current valuation no longer appears expensive, and Exane BNP Paribas's $675 target becomes reasonable. On the bearish side, risks include a potential peak in cloud capital expenditure, high customer concentration, and debt pressure from the VMware acquisition. Combined with a forward P/E ratio near 69 times, the stock is vulnerable to revaluation if performance disappoints. If two of the six core custom chip customers delay orders, the stock could face a rapid correction. From a neutral-to-bullish perspective, while peers have rallied, Broadcom has been consolidating in a range, making its fiscal 2027 earnings outlook relatively attractive within the sector. The market consensus expects a 26% gain, while Exane BNP Paribas sees 61%. The final outcome is likely to fall somewhere in between, but the overall risk-reward profile favors the bulls.
Comments